Causal Effects Of Immune Cell Populations On Biological Aging: A Mendelian Randomization Study

Aging Pathway
Therapeutic
Analytical
A study using genetic data has identified specific types of immune cells that can causally influence the speed at which a person biologically ages, suggesting potential targets for interventions to slow down aging.
Author

Gemini

Published

November 29, 2025

Our bodies are constantly changing, and one of the most complex processes we all experience is aging. While we know that our immune system plays a role in how we age, understanding the exact connections between specific immune cells and the pace of biological aging has been a challenge.

Recent research has shed new light on this intricate relationship by using a powerful genetic approach called Mendelian randomization. Think of it like a natural experiment where genetic variations, randomly assigned at birth, act as indicators for different immune cell levels. By analyzing these genetic variations, scientists can determine if certain immune cell populations directly cause changes in biological aging, rather than just being associated with it.

This study revealed that several types of immune cells have a causal impact on how quickly our bodies age. For instance, certain T-cells, specifically CD8+ T cells and CD28- CD8+ T cells, were found to be risk factors, meaning higher levels of these cells could accelerate biological aging. On the other hand, some immune cells, like unswitched memory B cells, appeared to have a protective effect, potentially slowing down the aging process. Other immune cell types, including certain monocytes and granulocytes, also showed significant links to aging acceleration.

These findings are a significant step forward because they move beyond simple correlations to identify direct cause-and-effect relationships. This understanding is crucial for developing new strategies to promote healthy aging. By pinpointing specific immune cell populations that influence aging, researchers can now explore targeted therapies that could modulate these cells, potentially leading to interventions that slow down or even reverse aspects of biological aging.


Source: link to paper